Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (72 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > I wonder if ...
View:
Post by gojotv! on Jul 20, 2021 1:19pm

I wonder if ...

...we'd see a better result if the patients held in the formula a little longer.
Maybe it takes more time for cancer cells that have been treated with BCG to absorb the TLD-1433.
Another 15-20 minutes would be uncomfortable for the patients, but could be the tipping point that make all the difference.
And what about throat cancers? It would be easy to treat them using the same modality as bladder cancer... just gargle and go... providing TLD-1433 doesn't taste too bad...
Anyway, there's a long road of trials ahead, and right now, we're well ahead of competitors. The future is looking bright!
Comment by gebremeskel on Jul 20, 2021 1:43pm
gojotv! - While you're at it, do you have any tips for brain surgeons? Perhaps they could also benefit from your expertise.
Comment by gojotv! on Jul 20, 2021 3:41pm
Yeah, I have a tip for brain surgeons. "Get gebremeskel as a patient. He's stupid AF and needs a lot of work. You'll make a fortune." I was the one who proposed to Dr. Mandel that the pre-treatment scraping in the first three patients of Ph1 could be the cause of the cancer's appearance in their ureters. So, they stopped scraping for the next three, and voila! Two CR's ...more  
Comment by gebremeskel on Jul 20, 2021 4:14pm
Good Lord Gojo I had no idea ! We Theralase shareholders are in your debt ! My apologies. Without you the phase 1 would have been a bust ! Thank God Dr. Mandel is humble enough to take technical advice from a bullboard basement boy !
Comment by gojotv! on Jul 21, 2021 1:27am
You don't me or my science background, gebremeskel. The more you post, the dumber you look.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250